Salvo 2022.

Methods	RCT
Participants	Overweight/obesity
Interventions	Treatment as usual and MB‐EAT
Outcomes	Anxiety, depression, fasting blood glucose, HbA1C, lipid levels
Notes	Identified when updating current status of the ongoing studies table from November 2021 to May 2023 (see Table 5). Trial registration NCT02893150. Briefly, overweight and obese women on low incomes were randomised to treatment as usual (N = 48), mindfulness‐based health promotion (N = 40) and MB‐EAT (N = 45). Overall, there were no significant robust intervention effects on weight, HbA1C, lipids, or anxiety and depression.